Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2020 Filed Nov 4, 2020 22:48 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 5,172 | $90.01 | $465,528.62 |
DisclosureSEC source: 0001179110-20-010828 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 230,319 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $90.0094. The sold price range between $89.45 to $90.42. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| November 04, 2020 Filed Nov 4, 2020 22:48 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 5,057 | $88.92 | $449,681.59 |
DisclosureSEC source: 0001179110-20-010828 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 235,491 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $88.9226. The sold price range between $88.45 to $89.44. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| September 16, 2020 Filed Sep 16, 2020 23:56 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 300 | $76.15 | $22,843.50 |
DisclosureSEC source: 0001179110-20-009837 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 240,548 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F6 · price: The price reported in Column 4 is the average price of $76.1450. The sold price range between $76.06 to $76.19. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| September 16, 2020 Filed Sep 16, 2020 23:56 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 13,443 | $75.63 | $1,016,657.79 |
DisclosureSEC source: 0001179110-20-009837 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 240,848 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $75.6273. The sold price range between $75.03 to $76.02. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| September 15, 2020 Filed Sep 15, 2020 22:58 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-009789 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,993 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 23:56 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,400 | $75.01 | $105,008.96 |
DisclosureSEC source: 0001179110-20-009837 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 254,291 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $75.0064. The sold price range between $75.00 to $75.03. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:31 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
GrantStock Options NQ (Right to Buy) · Derivative | 6,301 | $0.00 Strike: $68.04 | $0.00 |
DisclosureSEC source: 0001179110-20-008843 · edgar.xml · derivative · entry 3 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,301 Underlying: Common Stock · 6,301 shares Expires 2030-08-05 F2 · shares: NQ: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:31 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
GrantCommon Stock | 2,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008843 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,183 F1 · shares: RSU: Restricted Stock Units shall vest quarterly with one year cliff on 9/15,12/15,3/15 and 6/15 for a period of 4 years. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 16:42 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 3,718 | $75.15 | $279,398.41 |
DisclosureSEC source: 0001179110-20-008559 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,398 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $75.1475. The sold price range between $75.00 to $75.57. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 29, 2020 Filed Sep 2, 2020 23:34 UTC Amendment |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 3,718 | $75.15 | $279,398.41 |
DisclosureSEC source: 0001179110-20-009495 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 255,691 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · shares: 3718 shares were sold from shares held in trust with Mr. Lipps' wife. This is to just adjust the balance between directly held and indirectly held balances. F4 · price: The price reported in Column 4 is the average price of $75.1475. The sold price range between $75.00 to $75.57. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: 3718 shares were sold from shares held in trust with Mr. Lipps' wife. This is to just adjust the balance between directly held and indirectly held balances. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:09 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,025 | $67.99 | $69,688.11 |
DisclosureSEC source: 0001179110-20-007502 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,260 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $67.9884. The sold price range between $67.74 to $68.74. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:09 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,100 | $67.44 | $74,181.03 |
DisclosureSEC source: 0001179110-20-007502 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,285 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $67.4373. The sold price range between $66.74 to $67.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:30 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 10,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007413 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F4 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:29 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007412 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,979 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:29 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007411 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,385 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:28 UTC |
Kuipers Peter J.Executive V P& CFO
|
Tax withholdingCommon Stock | 3,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007410 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,590 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:28 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Tax withholdingCommon Stock | 1,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007409 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,098 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:27 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Tax withholdingCommon Stock | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007408 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,787 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| May 26, 2020 Filed May 27, 2020 16:07 UTC |
Scott Bruce EDirector
|
GrantCommon Stock | 2,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006628 · edgar.xml · nonDerivative · entry 2 Scott Bruce E · CIK 0001776980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,503 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:10 UTC |
Bauer Joanne BDirector
|
GrantCommon Stock | 2,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006626 · edgar.xml · nonDerivative · entry 2 Bauer Joanne B · CIK 0001359343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,704 F1 · shares: Grant of restricted shares in consideration of services as a member of the Board of Directors. Shares vest in full on the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:10 UTC |
Smith Bruce D.Director
|
GrantCommon Stock | 2,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006624 · edgar.xml · nonDerivative · entry 2 Smith Bruce D. · CIK 0001635537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,726 F1 · shares: Grant of restricted shares in consideration of service as a Board member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:10 UTC |
PARRISH MARK WDirector
|
GrantCommon Stock | 2,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006625 · edgar.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,235 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:09 UTC |
Judson James TDirector
|
GrantCommon Stock | 2,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006623 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,868 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:09 UTC |
WHITE SARA JDirector
|
GrantCommon Stock | 2,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006622 · edgar.xml · nonDerivative · entry 2 WHITE SARA J · CIK 0001227559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,735 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:08 UTC |
Seim Robin GeneDirector
|
GrantCommon Stock | 2,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006621 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,877 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:08 UTC |
Moore Vance B.Director
|
GrantCommon Stock | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006620 · edgar.xml · nonDerivative · entry 2 Moore Vance B. · CIK 0001550553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,017 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:42 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionEmployee Stock Option NQ (right to buy) · Derivative | 5,500 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:42 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 5,500 | $60.39 | $332,145.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: NQ Cash Exercise, no sales. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:42 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionEmployee Stock Option NQ (right to buy) · Derivative | 2,450 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,450 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:42 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 2,450 | $59.36 | $145,432.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: NQ Cash Exercise, no sales. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 896 | $68.00 | $60,925.04 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · I Trust with Wife Disclosed balance after: 259,409 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F7 · price: The price reported in Column 4 is the average price of $67.9967. The sold price range between $67.54 to $68.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 800 | $66.95 | $53,560.96 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 260,305 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $66.9512. The sold price range between $66.51 to $67.24. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 2,155 | $65.83 | $141,859.56 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 261,105 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $65.8281. The sold price range between $65.35 to $66.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,149 | $64.60 | $74,220.92 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 263,260 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $64.5961. The sold price range between $64.34 to $64.84. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:13 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,950 | $63.63 | $124,077.53 |
DisclosureSEC source: 0001179110-20-004588 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 264,409 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $63.6295. The sold price range between $63.36 to $64.34. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:13 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 2,700 | $62.72 | $169,331.04 |
DisclosureSEC source: 0001179110-20-004588 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 266,359 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $62.7152. The sold price range between $62.13 to $63.1250. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:13 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 350 | $60.63 | $21,222.01 |
DisclosureSEC source: 0001179110-20-004588 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 269,059 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $60.6343. The sold price range between $60.28 to $60.76. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| March 15, 2020 Filed Mar 16, 2020 18:24 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 190 | $74.48 | $14,151.20 |
DisclosureSEC source: 0001179110-20-003694 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,169 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:16 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Tax withholdingCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003036 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,749 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:16 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Tax withholdingCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003038 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,337 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:16 UTC |
Kuipers Peter J.Executive V P& CFO
|
Tax withholdingCommon Stock | 679 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003035 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,339 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:15 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003033 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,472 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:15 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 4,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003032 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,402 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 19, 2020 Filed Feb 19, 2020 23:29 UTC |
Bauer Joanne BDirector
|
SaleCommon Stock | 2,019 | $88.34 | $178,362.70 |
DisclosureSEC source: 0001179110-20-001907 · edgar.xml · nonDerivative · entry 3 Bauer Joanne B · CIK 0001359343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,916 F1 · price: The price reported in Column 4 is the average price of $88.3421. The sold price range between $88.31 to $88.3450. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2020 Filed Feb 19, 2020 23:29 UTC |
Bauer Joanne BDirector
|
SaleCommon Stock | 900 | $88.61 | $79,749.00 |
DisclosureSEC source: 0001179110-20-001907 · edgar.xml · nonDerivative · entry 2 Bauer Joanne B · CIK 0001359343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,935 F2 · price: The price reported in Column 4 is the exact price of $88.61. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 4,875 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 10 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,875 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 3,267 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,267 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 3,856 | $89.79 | $346,220.99 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,018 F5 · price: The price reported in Column 4 is the average price of $89.7876. The sold price range between $90.02 to $90.38. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 7,411 | $89.79 | $665,415.90 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,874 F4 · price: The price reported in Column 4 is the average price of $89.7876. The sold price range between $89.09 to $89.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.